Incannex Healthcare - Edison Group

Overview
Research
Sector insights
Thematics

Latest Insights

View More

Healthcare |
Update

01.06.23

Incannex Healthcare — Spotlight on Incannex’s progress in psychedelics

Healthcare |
Flash note

18.05.23

Incannex Healthcare — On the road to psychotherapy clinics

Healthcare |
Flash note

03.05.23

Incannex Healthcare — On to Phase II for IHL-675A

Healthcare |
Flash note

02.05.23

Incannex Healthcare — A clinically active quarter

incannex07

Sector

Healthcare

Research

Update

Healthcare

07.12.22

Incannex Healthcare — Expanding base with A$13m private placement

edison tv

Healthcare

02.12.22

Incannex Healthcare: Disrupting the obstructive sleep apnoea space with IHL-42

incannex07

Healthcare

Flash note

Incannex Healthcare — Progressing the opportunity in anxiety treatment

incannex07

Flash note

Healthcare

18.11.22

Incannex Healthcare — IHL-42X gearing up for FDA studies

Flash note

Healthcare

31.10.22

Incannex Healthcare — An encouraging start to the new financial year

Flash note

Healthcare

14.10.22

Incannex Healthcare — Positive Phase I data for IHL-675A

Flash note

Healthcare

12.10.22

Incannex Healthcare — Constructive pre-IND FDA meeting for IHL-216A

Update

Healthcare

23.09.22

Incannex Healthcare — Targeting FDA studies in FY23

incannex07

Initiation

Healthcare

30.08.22

Incannex Healthcare — Addressing unmet needs via alternative approach

Incannex mother and child

QuickView

Healthcare

08.08.22

Incannex Healthcare — APIRx acquisition to bolster portfolio

Further insights

insight

Healthcare

28.11.23

Incannex’s US redomicile is now complete – what’s next?

insight

Healthcare

20.07.23

Incannex Healthcare: Is life better on Nasdaq?

Incannex mother and child

insight

Healthcare

18.05.23

Incannex Healthcare: Data opens path to treat anxiety

insight

Healthcare

09.12.22

Healthcare Week 2023

thumbnail_incannex

insight

Healthcare

02.12.22

Incannex Healthcare: Disrupting the obstructive sleep apnoea space with IHL-42X

insight

Healthcare

30.09.22

Seven things every investor needs to know about Incannex Healthcare

thematic

Healthcare

13.06.23

ASCO 2023 key takeaways

thematic

Healthcare

26.01.23

Machine learning in drug development

thematic

Healthcare

06.01.23

Outlook for 2023: Biotechs remain central to novel drug development

Cancer cells

thematic

Healthcare

04.01.23

Oncology ABCs (part four): Blood cancers (AML) – notable innovations

cell DNA double helix

thematic

Healthcare

20.12.22

Cell and gene therapies

thematic

Healthcare

28.11.22

Drug delivery platforms

thematic

Healthcare

07.11.22

Oncology ABCs (part three) – thinking outside the box in women’s cancer

thematic

Healthcare

01.11.22

Neuroscience comeback

thematic

Consumer

05.10.22

IPO apocalypse

thematic

Healthcare

03.10.22

Oncology ABCs (part two) – vaccines: niche no longer

thematic

TMT

10.08.22

ESG, moving beyond the box tick

thematic

Healthcare

01.07.22

Oncology ABCs (part one) – a small-cap biopharma prospectus series

thematic

Healthcare

26.04.22

Cannabinoid manufacturing – Innovative approaches to the production of cannabinoids

thematic

Healthcare

10.11.21

Artificial intelligence in drug discovery

thematic

Healthcare

27.07.21

Biosynthesis – Taking the cannabinoid market to new heights

thematic

Healthcare

22.03.21

Seven things every investor should know about SIGA technologies & biological weapons

thematic

Healthcare

01.02.21

Confidence renewed as new COVID-19 vaccines demonstrate protection against emergent strains and efficacy with a single-dose regimen

thematic

Healthcare

30.10.19

Edison Exhibits- antibiotic development

thematic

Healthcare

17.07.19

The next wave in AMD

thematic

Healthcare

18.06.19

The A-B-T of biosimilars- Explaining contemporary life science issues

thematic

Healthcare

10.06.19

Cannabinoid Therapies- The coming retail wave

thematic

Healthcare

22.05.19

Cannabinoid Therapies- Therapeutics turning a corner

thematic

Healthcare

08.04.19

Trial outcomes and value – Explaining contemporary clinical trial issues

thematic

Healthcare

04.03.19

Drug pricing – Market access and reimbursement

thematic

Healthcare

29.01.19

The diagnostics sector

thematic

Healthcare

21.06.17

ASCO 2017

thematic

Consumer

11.11.14

Deutsche Börse Eigenkapitalforum 2014 Research Guide

thematic

Healthcare

05.03.14

Edison healthcare quarterly: A boost for allergy immunotherapy

thematic

Energy & Resources

04.03.14

ASX Spotlight Conference – London, 6 March 2014

thematic

Energy & Resources

01.03.13

ASX Small to Mid Caps Conference – London, 7 March 2013

thematic

Healthcare

07.12.12

Edison healthcare quarterly: Boom times for US biotech

thematic

Healthcare

30.08.12

Edison healthcare quarterly: Crisis? What crisis?

thematic

Healthcare

28.05.12

Edison healthcare quarterly: How to please some of the people some of the time